Rinri Therapeutics Limited
- Company number
- 11680455
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 15 Nov 2018
- Nature of business
- Research and experimental development on biotechnology
- Corporate group
- GMV Nominees Ltd (48294 companies)
Registered office
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Professor Carlos Marcelo Nicolas Rivolta | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
15 Nov 2018 | 22 Feb 2019 |
| Uk Ff Nominees Limited | Ownership Of Shares 25 To 50 Percent Voting Rights 25 To 50 Percent |
4 Mar 2026 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2024 | - | - | - |
| 31 Dec 2023 | -£10,666,023 | £4,902,218 | 11 |
| 31 Dec 2022 | - | - | - |
| 31 Dec 2021 | - | - | - |
| 31 Dec 2020 | - | - | - |
| 31 Dec 2019 | - | - | - |
Connections
Owned by
Rinri Therapeutics Limited → UK Ff Nominees Limited → UK Ff Topco Limited → CSC Corporate Services (UK) Limited → CSC Capital Markets UK Limited → CSC Capital Markets Holding Company Limited